Clinical Study of Shenfu Injection in the Treatment of Acute Inferior Myocardial Infarction

Xiangshan XU,Yuanzhe JIN
DOI: https://doi.org/10.13194/j.issn.1673-842x.2017.06.055
2017-01-01
Abstract:Objective:To evaluate the efficacy and safety of Shenfu Injection in the treatment of acute inferior and right ventricle myocardial infarction combined with hypotension patients.Methods:To summarize 50 patients with acute inferior and right ventricular myocardial infarction combined with hypotension state in our hospital between January 2014 and December 2016,including Shenfu group (treatment group)25 cases and dopamine group (control group) in 25 cases.The clinical efficacy and safety was observed.Results:The blood pressure of treatment group raised significantly than the control group 96% vs 88% (P<0.05),the treatment group showed no adverse reaction.In addition,the level of BNP and CRP decreased significantly in treatment group than that in the control group.Conclusion:Shenfu Injection is efficient and safe in the treatment of acute inferior and right ventricular myocardial infarction with hypotension.
What problem does this paper attempt to address?